Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $22.85 and traded as high as $24.30. Fresenius Medical Care AG & Co. KGaA shares last traded at $24.0750, with a volume of 509,060 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on FMS. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Zacks Research raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Sanford C. Bernstein began coverage on Fresenius Medical Care AG & Co. KGaA in a research report on Thursday. They issued a “market perform” rating on the stock. Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Finally, Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research report on Friday, May 8th. Six analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Stock Performance

The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.40. The firm has a 50-day moving average of $22.79 and a 200 day moving average of $22.85. The stock has a market capitalization of $12.93 billion, a P/E ratio of 12.67, a PEG ratio of 4.35 and a beta of 0.78.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its quarterly earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The firm had revenue of $5.34 billion for the quarter. Research analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently announced an annual dividend, which was paid on Monday, June 8th. Stockholders of record on Friday, May 22nd were given a dividend of $0.8716 per share. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. The ex-dividend date was Friday, May 22nd. This represents a dividend yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is presently 32.11%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Pzena Investment Management LLC boosted its holdings in Fresenius Medical Care AG & Co. KGaA by 2.0% during the first quarter. Pzena Investment Management LLC now owns 15,052,822 shares of the company’s stock valued at $339,592,000 after purchasing an additional 299,986 shares in the last quarter. Morgan Stanley grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 47.2% in the 4th quarter. Morgan Stanley now owns 2,939,839 shares of the company’s stock valued at $70,027,000 after purchasing an additional 942,497 shares during the period. Integral Health Asset Management LLC raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 44.4% in the 4th quarter. Integral Health Asset Management LLC now owns 650,000 shares of the company’s stock worth $15,483,000 after buying an additional 200,000 shares in the last quarter. Moran Wealth Management LLC raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 31.5% in the 1st quarter. Moran Wealth Management LLC now owns 347,773 shares of the company’s stock worth $7,846,000 after buying an additional 83,311 shares in the last quarter. Finally, Quantinno Capital Management LP lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 15.7% during the 1st quarter. Quantinno Capital Management LP now owns 341,343 shares of the company’s stock worth $7,701,000 after buying an additional 46,428 shares during the period. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.